Variability of Shigella flexneri serotypes in Israel during a period of two years: 2000 and 2001

During a period of 2 years (2000 and 2001) 996 Shigella flexneri strains from sporadic cases in Israel were sent to the National Shigella Reference Centre (NSRC) by hospital and outpatient clinics. The most common serotypes were 2a, 6 and 1b, accounting for 88·4% of all isolates. They were investigated according to the monthly distribution of the strains, and the age and sex of the patients. The severity of the disease was assessed by a hospital/outpatient distribution (H/Od) of the isolates, based on the location of the sending laboratory. The most affected age groups were 0–11 months and 1–4 years, and the prevalent serotype was 2a, while serotype 6 was dominant in the 5–14 years age group. More cases were registered during the hot season, and there were some serotype-related variations. Overall, 62·1% of the samples were from male patients. Serotype 1b was dominant in the male/female ratio, although it was third in general prevalence. According to the H/Od serotype 2a was more common in hospitalized males and serotype 6 in outpatients, both male and female. These variations, as well as changes in serotype prevalence in the past, underscore the importance of serotype monitoring as part of the public health strategies for reducing the burden of Shigella flexneri infections.

[1]  G. Nair,et al.  Shifting serotypes, plasmid profile analysis and antimicrobial resistance pattern of shigellae strains isolated from Kolkata, India during 1995–2000 , 2002, Epidemiology and Infection.

[2]  D. Sack,et al.  Altering Trends in the Dominance of Shigella flexneri Serotypes and Emergence of Serologically AtypicalS. flexneri Strains in Dhaka, Bangladesh , 2001, Journal of Clinical Microbiology.

[3]  A. Mates,et al.  Antimicrobial Resistance Trends in Shigella Serogroups Isolated in Israel, 1990–1995 , 2000, European Journal of Clinical Microbiology and Infectious Diseases.

[4]  D. Maneval,et al.  Strategy for Cross-Protection among Shigella flexneri Serotypes , 1999, Infection and Immunity.

[5]  D. N. Taylor,et al.  Cross-reactivity of Shigella flexneri serotype 2a O antigen antibodies following immunization or infection. , 1996, Vaccine.

[6]  H. Lior,et al.  Evaluation of commercial antisera for Shigella serogrouping , 1995, Journal of clinical microbiology.

[7]  Z. Samra,et al.  Recent trends in the epidemiology of Shigella species in Israel. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  M. Levine,et al.  Epidemiologic patterns of acute diarrhea and endemic Shigella infections in children in a poor periurban setting in Santiago, Chile. , 1991, American journal of epidemiology.

[9]  Manfred S. Green,et al.  Four decades of shigellosis in Israel: epidemiology of a growing public health problem. , 1991, Reviews of infectious diseases.

[10]  D. A. Simmons,et al.  Structure and biology of Shigella flexneri O antigens. , 1987, Journal of medical microbiology.

[11]  P. Sansonetti,et al.  The Genus Shigella , 2006 .

[12]  D. Swerdlow,et al.  Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. , 1999, Bulletin of the World Health Organization.

[13]  E. Anis,et al.  Shigellosis in Israel--update 1995. , 1996, Public health reviews.

[14]  C. Block,et al.  Development of antimicrobial drug resistance among Shigellas isolated at an Israeli hospital from 1977 through 1990. , 1990, Public health reviews.

[15]  D. Michaeli,et al.  The epidemiology of shigellosis in Israel. , 1988, Annals of tropical medicine and parasitology.

[16]  W. Ewing,et al.  Edwards and Ewing's Identification of Enterobacteriaceae , 1986 .